Looking Into TG Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
TG Therapeutics (NYSE:TGTX) has seen a decrease in short interest, with the short percent of float dropping 12.86% since the last report. The company has 31.83 million shares sold short, representing 25.88% of available shares. The average time to cover these short positions is 6.52 days. Short interest is a market sentiment indicator, and TG Therapeutics currently has a higher short interest than its peer group average of 15.13%.
January 19, 2024 | 6:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TG Therapeutics's short interest has decreased, which could indicate a more bullish sentiment among investors. However, the high percentage of float shorted compared to peers suggests caution.
A decrease in short interest typically suggests that investors are becoming more bullish on the stock. However, the fact that TG Therapeutics still has a higher short interest than its peers means the sentiment is not entirely positive. The impact on the stock price is uncertain, hence a neutral score is given.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100